Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion type Assertion NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_head.
- NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion description "[To this aim, 21 invasive urothelial cell carcinomas of the renal pelvis and 27 high-grade renal cell carcinomas (8 renal cell carcinomas with sarcomatoid dedifferentiation and 5 type 1 and 7 type 2 papillary renal cell carcinomas as well as 7 collecting duct carcinomas) were stained with antibodies directed against protein gene product 9.5, CD10, vimentin, CEA, p63, CK5/6, CK7, CK20, PAX2, PAX8, CD117 (c-Kit), AE1/3, ?-methyl CoA racemase, actin, and desmin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_provenance.
- NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion evidence source_evidence_literature NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_provenance.
- NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion SIO_000772 23158209 NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_provenance.
- NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion wasDerivedFrom befree-2016 NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_provenance.
- NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_assertion wasGeneratedBy ECO_0000203 NP1029052.RAfuBpcCp9YFpADyNcrcaJZEzLiPmAvepzacL__A62IcE130_provenance.